ES2699722R1 - Composicion para tratar enfermedades de las neuronas motoras y uso de la misma - Google Patents
Composicion para tratar enfermedades de las neuronas motoras y uso de la mismaInfo
- Publication number
- ES2699722R1 ES2699722R1 ES201890043A ES201890043A ES2699722R1 ES 2699722 R1 ES2699722 R1 ES 2699722R1 ES 201890043 A ES201890043 A ES 201890043A ES 201890043 A ES201890043 A ES 201890043A ES 2699722 R1 ES2699722 R1 ES 2699722R1
- Authority
- ES
- Spain
- Prior art keywords
- composition
- same
- motor neurons
- treat diseases
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 210000002161 motor neuron Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510969710.XA CN107115332A (zh) | 2015-12-21 | 2015-12-21 | 一种用于治疗运动神经元病的组合物及其用途 |
| CN201611153606.4A CN107184582A (zh) | 2016-12-14 | 2016-12-14 | 一种用于治疗运动神经元病的组合物及其用途 |
| PCT/CN2016/110316 WO2017107863A1 (zh) | 2015-12-21 | 2016-12-16 | 一种用于治疗运动神经元病的组合物及其用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ES2699722A2 ES2699722A2 (es) | 2019-02-12 |
| ES2699722R1 true ES2699722R1 (es) | 2019-03-08 |
| ES2699722B1 ES2699722B1 (es) | 2020-01-02 |
Family
ID=59089153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201890043A Active ES2699722B1 (es) | 2015-12-21 | 2016-12-16 | Composicion para tratar enfermedades de las neuronas motoras y uso de la misma |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3395341A4 (es) |
| CH (1) | CH713469B1 (es) |
| DE (1) | DE112016005857T5 (es) |
| ES (1) | ES2699722B1 (es) |
| GB (1) | GB2561747B (es) |
| WO (1) | WO2017107863A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| JP7266581B2 (ja) | 2017-08-14 | 2023-04-28 | アクセラ・ヘルス・インコーポレイテッド | 肝疾患の治療のためのアミノ酸組成物 |
| US10596136B2 (en) | 2018-06-20 | 2020-03-24 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
| CN114469941A (zh) * | 2020-10-27 | 2022-05-13 | 河北科星药业有限公司 | 用于畜疾病防治的复合氨基酸注射液及其制备方法和应用 |
| DE102022004219A1 (de) | 2022-11-15 | 2024-05-16 | Peter Meyer | Aminosäurenkombination mit Vitamin C und B6 zur präventiven, kurativen und rehabilitativen Behandlung von Stoffwechselstörungen im Kohlenhydratstoffwechsel, Proteinstoffwechsel und Fettstoffwechsel sowie bei physischen und/oder psychischen Leistungsverlust. |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2601951A1 (en) * | 2010-08-06 | 2013-06-12 | Maoxing Yue | Pharmaceutical composition for treating hemorrhage caused by blood clotting disorder and use thereof |
| EP2881112A1 (en) * | 2012-08-01 | 2015-06-10 | Maoxing Yue | Pharmaceutical composition for promoting nerve injury restoration and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002236527A1 (en) * | 2000-11-30 | 2002-06-11 | The Health Research Institute | Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| CN106572986A (zh) * | 2014-03-10 | 2017-04-19 | 本杰明·M·余 | 用于经皮递送的方法和组合物 |
| CN104055773B (zh) * | 2014-07-03 | 2016-05-25 | 万红贵 | 一种降血脂组合物及其应用 |
| CN107184582A (zh) * | 2016-12-14 | 2017-09-22 | 岳茂兴 | 一种用于治疗运动神经元病的组合物及其用途 |
-
2016
- 2016-12-16 EP EP16877674.8A patent/EP3395341A4/en active Pending
- 2016-12-16 GB GB1809655.2A patent/GB2561747B/en active Active
- 2016-12-16 CH CH00785/18A patent/CH713469B1/de unknown
- 2016-12-16 DE DE112016005857.8T patent/DE112016005857T5/de active Pending
- 2016-12-16 ES ES201890043A patent/ES2699722B1/es active Active
- 2016-12-16 WO PCT/CN2016/110316 patent/WO2017107863A1/zh active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2601951A1 (en) * | 2010-08-06 | 2013-06-12 | Maoxing Yue | Pharmaceutical composition for treating hemorrhage caused by blood clotting disorder and use thereof |
| EP2881112A1 (en) * | 2012-08-01 | 2015-06-10 | Maoxing Yue | Pharmaceutical composition for promoting nerve injury restoration and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3395341A1 (en) | 2018-10-31 |
| WO2017107863A1 (zh) | 2017-06-29 |
| GB201809655D0 (en) | 2018-08-01 |
| ES2699722B1 (es) | 2020-01-02 |
| GB2561747A (en) | 2018-10-24 |
| CH713469B1 (de) | 2021-06-30 |
| DE112016005857T5 (de) | 2018-11-15 |
| ES2699722A2 (es) | 2019-02-12 |
| EP3395341A4 (en) | 2019-08-07 |
| GB2561747B (en) | 2021-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201517215D0 (en) | Use of cannabinoids in the treatment of inflammatory skin diseases | |
| EP3349783C0 (en) | COMPOSITIONS AND METHODS ASSOCIATED WITH THE TREATMENT OF DISEASES | |
| CL2016002364A1 (es) | Indazol-3-carboxamidas 5-sustituidas y preparación y uso de las mismas | |
| CL2018002814A1 (es) | Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel. | |
| BR112017001789A2 (pt) | composições e métodos de uso para tratamento de distúrbios metabólicos | |
| BR112016026378A2 (pt) | formulações e métodos para tratamento com queratina | |
| BR112015022854A2 (pt) | pró-farmacos de fumaratos e uso do mesmo no tratamento de várias doenças | |
| CL2018000708A1 (es) | Fitasas modificadas y métodos de uso | |
| ES2820879R1 (es) | Composiciones para la liberación controlada de ingredientes activos y métodos de preparación de las mismas | |
| BR112018000129A2 (pt) | oxiesteróis e seus métodos de utilização | |
| CL2016002300A1 (es) | Combinaciones de principios activos insecticidas y nematocidas | |
| FR3021533B1 (fr) | Composition cosmetique de type gel | |
| CO2017007121A2 (es) | Compuestos bicíclicos fusionados para el tratamiento de enfermedades | |
| ES2969758T3 (es) | Composiciones farmacéuticas para usar en la terapia de la blefaritis | |
| BR112016021034A2 (pt) | Composição farmacêutica, uso de tal composição, método para tratar uma doença e kit | |
| ES2699722R1 (es) | Composicion para tratar enfermedades de las neuronas motoras y uso de la misma | |
| BR112014016389A8 (pt) | composições e uso das mesmas para o tratamento de distúrbios e doenças hepáticas | |
| MA46788A (fr) | Traitement de la fibrose | |
| CL2016001921A1 (es) | Proteínas inmovilizadas y uso de las mismas | |
| GB201404403D0 (en) | Compositions and methods relating to the treatment of diseases | |
| FR3022139B1 (fr) | Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee | |
| ES1178860Y (es) | Atuendo para facilitar la utilizacion de piedras para chakras | |
| CL2015000537A1 (es) | Siarn y su uso en los métodos y composiciones para el tratamiento y/o prevención de enfermedades de los ojos. | |
| ES2759940T8 (es) | Compuestos de 1,3,4-tiadiazol y su uso para tratar el cáncer | |
| FR3025098B1 (fr) | Composition cosmetique de type gel facilement demaquillable |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA2A | Patent application published |
Ref document number: 2699722 Country of ref document: ES Kind code of ref document: A2 Effective date: 20190212 |
|
| EC2A | Search report published |
Ref document number: 2699722 Country of ref document: ES Kind code of ref document: R1 Effective date: 20190301 |
|
| FG2A | Definitive protection |
Ref document number: 2699722 Country of ref document: ES Kind code of ref document: B1 Effective date: 20200102 |